Skip to main content

Table 5 Efficiency of cefaclor in patients with in vitro resistance to specific antibiotics including levofloxacin and cefazolin

From: Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study

Antimicrobial agent

n

Success

Pathogen

n

Success

Levofloxacin

24 (10.3)

24 (100)

Escherichia coli

17 (70.8)

17 (100)

Escherichia coli-ESBL

1 (4.1)

1 (100)

Cefazolin

15 (6.4)

14 (93.3)

Escherichia coli

3 (20.0)

3 (100)

Escherichia coli-ESBL

3 (20.0)

2 (66.6)

Levofloxacin and cefazolin

15 (6.4)

9 (60.0)

Escherichia coli

1 (6.7)

1 (100)

Escherichia coli-ESBL

14 (93.3)

8 (57.1)

  1. Unless otherwise stated, number of patients with percentages in parentheses
  2. ESBL Extended spectrum beta-lactamase